Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,099 | Dovepress* | 6,851+ | 1,101 | 7,952 | |
| PubMed Central* | 1,248 | 450 | 1,698 | ||
| Totals | 8,099 | 1,551 | 9,650 | ||
| *Since 20 March 2019 | |||||
View citations on PubMed Central and Google Scholar